ADAM Bisaga

Affiliations: 
Columbia University, New York, NY 
Area:
addiction, pharmacotherapy
Google:
"ADAM Bisaga"
Mean distance: 53433
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Bedi G, Shiffrin L, Vadhan NP, et al. (2016) Effects of levodopa-carbidopa-entacapone and smoked cocaine on facial affect recognition in cocaine smokers. Journal of Psychopharmacology (Oxford, England)
Levin FR, Mariani JJ, Pavlicova M, et al. (2015) Dronabinol and lofexidine for cannabis use disorder: A randomized, double-blind, placebo-controlled trial. Drug and Alcohol Dependence
Bisaga A, Sullivan MA, Glass A, et al. (2015) The effects of dronabinol during detoxification and the initiation of treatment with extended release naltrexone. Drug and Alcohol Dependence
Mogali S, Khan NA, Drill ES, et al. (2015) Baseline characteristics of patients predicting suitability for rapid naltrexone induction. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 24: 258-64
Levin FR, Mariani JJ, Bisaga A, et al. (2015) Ling et al.'s 'Sustained-release methylphenidate in a randomized trial of treatment of methamphetamine use disorder'. Addiction (Abingdon, England). 110: 875-6
Sullivan MA, Bisaga A, Glass A, et al. (2015) Opioid use and dropout in patients receiving oral naltrexone with or without single administration of injection naltrexone. Drug and Alcohol Dependence. 147: 122-9
Kelly MA, Pavlicova M, Glass A, et al. (2014) Do withdrawal-like symptoms mediate increased marijuana smoking in individuals treated with venlafaxine-XR? Drug and Alcohol Dependence. 144: 42-6
Mariani JJ, Pavlicova M, Mamczur AK, et al. (2014) Open-label pilot study of quetiapine treatment for cannabis dependence. The American Journal of Drug and Alcohol Abuse. 40: 280-4
Bisaga A, Sullivan MA, Glass A, et al. (2014) A placebo-controlled trial of memantine as an adjunct to injectable extended-release naltrexone for opioid dependence. Journal of Substance Abuse Treatment. 46: 546-52
Raby WN, Rubin EA, Garawi F, et al. (2014) A randomized, double-blind, placebo-controlled trial of venlafaxine for the treatment of depressed cocaine-dependent patients. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 23: 68-75
See more...